Copy
View this email in your browser
The Journey Newsletter (October 2024)
October features three in-person events across three different continents, including the 2024 Global Symposium, which takes place Oct. 22-24 in New Brunswick, N.J. Registration information for the India, EHDEN and Global, as well as the Asia-Pacific (Dec. 4-8), Symposiums is available in this newsletter. You can also find the 2024 Titan Award nominees, recent publications out of the community, a collaborator spotlight with Yong Chen, and plenty more. #JoinTheJourney
Videocast: Symposia Around The World
In the latest On The Journey videocast, Patrick Ryan and Craig Sachson discuss the excitement of three in-person events coming up in October, including the first India Symposium and an EHDEN Symposium. They also discuss how newcomers can benefit from joining the community at the 2024 Global Symposium in New Brunswick, N.J. (if video does not appear, please click 'View this email in your browser')
Community Updates
Where Have We Been?
• The LEGEND-T2DM team published Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes; A Multinational, Federated Analysis of LEGEND-T2DM in the Journal of the American College of Cardiology last month. This study will be discussed during the plenary at the upcoming Global Symposium.
• The Vocabulary team completed its August 2024 refresh, and it shared many of the updates and changes during a recent community call. 
• The Book of OHDSI was published five years ago and introduced at the 2019 Symposium. It was developed by community volunteers to be a central knowledge repository for OHDSI, and it focuses on describing our community, data standards, and tools. We looked back at the book's development and impact during a September community call.
• 72 individuals or teams were nominated for a 2024 Titan Award (see graphic below). These nominations were made by fellow collaborators within the OHDSI community, and the award winners will be announced during the Global Symposium.



Where Are We Now?
• Registration is open for the 2024 OHDSI Global Symposium, which will be held October 22-24 at the Hyatt Regency Hotel in New Brunswick, N.J., USA. The event will include a day of tutorials, a day of plenaries and the collaborator showcase, and a day of workgroup activities. Check out the event homepage for more information.
• The first OHDSI India Symposium will be held Saturday, Oct. 5, at the Jio World Convention Centre in Mumbai, India. In association with the Global Digital Health Summit, this event is set to bring together more than 20 community leaders in the field of health data research for a day of sharing, learning and networking.
• The 2024 EHDEN Symposium will be held Oct. 10 in Barcelona, and it will include sessions on EHDEN and both Real-World Data and Real-World Evidence, as well as the EHDEN impact on regulatory decision making and the medical product industry. The full agenda is now available.

Where Are We Going?
Community calls will continue this month (Tuesdays, 11 am-12 pm ET), including an October 8 session focused on Advances in Methodological Research. There are talks planned on negative controls in vaccine research, new diagnostics for covariate balance in small samples, and the performance of the concurrent comparator design. If you don't receive the weekly call invite, the link to join is available here.
• Registration has opened for the 2024 OHDSI Asia-Pacific (APAC) Symposium, which will be held December 4-8 in Singapore. Regional co-chairs Mengling ‘Mornin’ Feng and Ngial Kee Yuan will lead this event, which has a theme of “When OHDSI Meets with AI.” Registration and agenda information is available on the homepage.
• The #OHDSISocialShowcase will include research from both the 2024 Europe and Global Symposiums this month. Please make sure you are following OHDSI’s LinkedInTwitter/X and Instagram feeds to receive daily updates on the research presented by our community.
OHDSI2024 Month Is Here! Registration Remains Open for the Global Symposium

Registration is open for the 2024 OHDSI Global Symposium, which will be held October 22-24 at the Hyatt Regency Hotel in New Brunswick, N.J., USA. The event will include a day of tutorials, a day of plenaries and the collaborator showcase, and a day of workgroup activities. Check out the event homepage for more information.

There are more than 130 posters/demos that will be shared during the Collaborator Showcase, including eight that will be featured as lightning talks during the main conference Wednesday. There will also be plenaries on 'Clinical Insights from LEGEND-T2DM' and 'Value Proposition for Participating in OHDSI Network Studies like LEGEND-T2DM', and there is a panel on the recent JACC-OHDSI Partnership. 

More details on the five tutorials, including the Introduction to OHDSI session, and the workgroup activities cane be found using the links below. We can't wait to see everybody later this month in New Brunswick!

Register for the OHDSI Global Symposium
2024 Global Symposium Homepage
First India Symposium Set For Oct. 5 in Mumbai; Wide Array of Community Leaders Set To Join

The first OHDSI India Symposium will be held Saturday, Oct. 5, at the Jio World Convention Centre in Mumbai, India. In association with the Global Digital Health Summit, this event is set to bring together more than 20 community leaders in the field of health data research for a day of sharing, learning and networking.

Following opening remarks by both Louis Hendriks and Dr. Rajendra Pratap Gupta, there will be an overview about the OHDSI community and a discussion about the OHDSI India chapter. There are also brief talks that will focus on the European Health Data Space, RWE & RWD in India, and Data Collection Challenges in Hospitals.

There will be a pair of panel discussions during the event, focusing on both leveraging real-world evidence to improve health outcomes in India, as well as the power of data in healthcare transformation. There will also be a two-hour collaborator showcase to highlight the exciting research taking place in the region. Registration remains open through Oct. 3 at 5:00 PM (Asia/Kolkata), and you can use the links below to register and/or learn more.

Register for the OHDSI India Symposium
OHDSI India Symposium Homepage

Dr. Yong Chen, Professor of Biostatistics, founded and directs the Computing, Inference, and Learning Lab (PENNCIL) at the University of Pennsylvania. The mission of the PENNCIL lab is to develop computational methods and software to transform real-world data into insights, to disseminate the methods and knowledge to research communities, and to bridge the gap from data to actionable health care.

Yong, who has been leading methodological work within the OHDSI community for several years, is an Elected Fellow in both the American Statistical Association (2020) and the the American College of Medical Informatics (ACMI) (2023), and he earned the 2021 OHDSI Titan Award for Methodological Research. His research areas include real-world data, clinical evidence generation, learning health systems and healthcare delivery.

In the latest edition of the Collaborator Spotlight, Yong discusses his career journey, recent advances in methods research, how his students use OHDSI in their research, and more.

Spotlight: Yong Chen
Registration Opens for the Asia-Pacific (APAC) Symposium, Held Dec. 4-8 in Singapore

Registration is now open for the 2024 OHDSI APAC Symposium, which will be held in Singapore at the Marina Bay Sands and the National University of Singapore (NUS). This year’s event will be co-hosted with Singapore’s International Medical AGI Network Event (IMAGINE) and will feature a 1-day tutorial, a 2-day main conference and a 2-day datathon.

The main conference will have sessions focused on the recent Community-Wide ETL Project, the 2024 APAC Study, Large Language Models and more. Registration information and detailed agendas can be found on the event homepage. We hope to see you in Singapore this December!

2024 APAC Symposium Homepage
OHDSI hosts community calls each Tuesday from 11 am-12 pm ET in our MS Teams environment. One session to highlight this month will take place October 8 and focus on Advances in Methodological Research. There are talks planned on negative controls in vaccine research, new diagnostics for covariate balance in small samples, and the performance of the concurrent comparator design. If you don't receive the weekly call invite, it is available on the community calls homepage.
OHDSI Community Calls
Publications
Khera R, Aminorroaya A, Dhingra LS, Thangaraj PM, Pedroso Camargos A, Bu F, Ding X, Nishimura A, Anand TV, Arshad F, Blacketer C, Chai Y, Chattopadhyay S, Cook M, Dorr DA, Duarte-Salles T, DuVall SL, Falconer T, French TE, Hanchrow EE, Kaur G, Lau WCY, Li J, Li K, Liu Y, Lu Y, Man KKC, Matheny ME, Mathioudakis N, McLeggon JA, McLemore MF, Minty E, Morales DR, Nagy P, Ostropolets A, Pistillo A, Phan TP, Pratt N, Reyes C, Richter L, Ross JS, Ruan E, Seager SL, Simon KR, Viernes B, Yang J, Yin C, You SC, Zhou JJ, Ryan PB, Schuemie MJ, Krumholz HM, Hripcsak G, Suchard MA. Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM. J Am Coll Cardiol. 2024 Sep 3;84(10):904-917. doi: 10.1016/j.jacc.2024.05.069. PMID: 39197980.

Choi S, Kim JK, Lee J, Choi SJ, Lee YK. Limitations of NHIC claim code-based surveillance and the necessity of UDI implementation in Korea. Sci Rep. 2024 Sep 9;14(1):21014. doi: 10.1038/s41598-024-72063-1. PMID: 39251861; PMCID: PMC11383859.

Cha JJ, Yum Y, Kim YH, Kim EJ, Rah YC, Park E, Im GJ, Song JJ, Chae SW, Choi J, Joo HJ. Association of the protective effect of telmisartan on hearing loss among patients with hypertension. Front Neurol. 2024 Aug 27;15:1410389. doi: 10.3389/fneur.2024.1410389. PMID: 39258156; PMCID: PMC11384575.

Sato A, Rodriguez-Molina D, Yoshikawa-Ryan K, Yamashita S, Okami S, Liu F, Farjat A, Oberprieler NG, Kovesdy CP, Kanasaki K, Vizcaya D. Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan-A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform. J Clin Med. 2024 Aug 28;13(17):5107. doi: 10.3390/jcm13175107. PMID: 39274317; PMCID: PMC11396164.

Tan EH, Burn E, Barclay NL, Delmestri A, Man WY, Golozar A, Serrano ÀR, Duarte-Salles T, Cornford P, Prieto Alhambra D, Newby D; OPTIMA Consortium. Incidence, Prevalence, and Survival of Prostate Cancer in the UK. JAMA Netw Open. 2024 Sep 3;7(9):e2434622. doi: 10.1001/jamanetworkopen.2024.34622. PMID: 39298169.

Park SI, Kim JK, Yu U, Park JI. Identification of factors associated with vancomycin-induced acute kidney injury: A retrospective analysis using the Common Data Model. Int J Clin Pharmacol Ther. 2024 Sep 24. doi: 10.5414/CP204646. Epub ahead of print. PMID: 39315482.

Luo M, Gu Y, Zhou F, Chen S. Implementation of the Observational Medical Outcomes Partnership Model in Electronic Medical Record Systems: Evaluation Study Using Factor Analysis and Decision-Making Trial and Evaluation Laboratory-Best-Worst Methods. JMIR Med Inform. 2024 Sep 27;12:e58498. doi: 10.2196/58498. PMID: 39331952.
Video Presentations
Sept. 3: Vocabulary Release Update
Presentation (Alexander Davydov, Masha Khitrun, Anna Ostropolets, Tanya Skugarevskaya)

Sept. 10: Asia-Pacific Regional Updates
Presentation (Jason Hsu, Seng Chan You, Keiko Asao, Nicole Pratt, Lei Liu, Mengling ‘Mornin’ Feng

Sept. 17: The Book of OHDSI, 5 Years Later
Presentation (Patrick Ryan, Martijn Schuemie, Chapter Leads)

Sept. 24: Recent OMOP/OHDSI Publications
Data harmonization and federated learning for multi-cohort dementia research using the OMOP common data model: A Netherlands consortium of dementia cohorts case study (Pedro Mateus)
KG-LIME: predicting individualized risk of adverse drug events for multiple sclerosis disease-modifying therapy (Jason Patterson)
Application of a Data Quality Framework to Ductal Carcinoma In Situ Using Electronic Health Record Data From the All of Us Research Program (Ami Ostchega)
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 (Asieh Golozar)
Twitter
LinkedIn
YouTube
Instagram
Website
GitHub
Email
Copyright © 2024 Observational Health Data Sciences and Informatics (OHDSI), All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp